Tag: cse:lxx
May 11, 2020
Lexaria Bioscience Confirms Closing of US$2,039,228 Private Placement
Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) confirms that its private placement financing. May 4, 2020
Lexaria Bioscience Announces Over US$2,000,000 Private Placement
Lexaria Bioscience has entered into definitive agreements with certain qualified investors for the sale of share and warrants to purchase... April 23, 2020
Lexaria Receives Notice of Allowance for New Patent and Awards Stock Options
Lexaria Bioscience (CSE:LXX) a global innovator in drug delivery platforms, has received a Notice of Allowance from the United States... April 21, 2020
Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19
Lexaria (CSE:LXX) has filed a new patent application in the US describing the use of its DehydraTECH(TM) technology for the... March 23, 2020
Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment
Lexaria Bioscience has expanded the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. March 19, 2020
Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Program
Lexaria Bioscience is commencing a program to study the benefits of Lexaria's DehydraTECHTM drug delivery platform in the fight against... March 17, 2020